Form 4: CME Group Director Charles P. Carey Receives Equity Grant Valued at Over $240,000

CME Group Inc. Director Charles P. Carey was granted 879 shares of Class A Common Stock as part of the company's Director Stock Plan, increasing his beneficial ownership.

Summary

• Charles P. Carey, a Director of CME Group Inc. (CME), acquired 879 shares of Common Stock Class A on June 25, 2025.
• The shares were acquired at a price of $273.03 per share, totaling approximately $240,000.
• This acquisition was a grant pursuant to the CME Group Director Stock Plan, as amended and restated.
• Following this transaction, Mr. Carey's beneficial ownership of CME Group Common Stock Class A includes 5,779 shares held indirectly by a Trust, 185 shares held indirectly by a Firm, and 0.375 shares held indirectly by a Partnership.

Sentiment

Score: 5

Explanation: The sentiment is neutral as the transaction represents a routine equity grant to a director as part of a compensation plan, rather than an open market purchase or sale that would typically signal stronger positive or negative sentiment.

Positives

• The acquisition of shares by a director increases insider ownership, aligning management interests with shareholders.
• The grant is part of a structured compensation plan, indicating stability in executive remuneration practices.

Future Outlook

The document does not contain any forward-looking statements or guidance regarding the company's future performance or strategic direction.

Industry Context

This filing is a routine disclosure of insider share transactions, common across all publicly traded companies, and reflects standard compensation practices for directors within the financial services industry, particularly for large exchange operators like CME Group.

Related Party Transactions

• Beneficial ownership includes shares held indirectly by a Trust, a Firm, and a Partnership, which may involve related parties, though the filing does not detail specific transactions with these entities beyond ownership.

Stakeholder Impact

• Shareholders may view the increase in director ownership as a positive signal of alignment with shareholder interests, although its nature as a grant rather than an open market purchase may temper the perceived significance.
• The grant reinforces the compensation structure for directors, impacting the company's overall governance and remuneration practices.

Key Dates

Keywords

CME Group, SEC Form 4, Insider Trading, Beneficial Ownership, Equity Grant, Director Compensation, Stock Acquisition, Financial Services, Derivatives Exchange